Congenital toxoplasmosis in France in 2007: First results from a national surveillance system

Eurosurveillance

Volumn 15, Issue 25, 2010, Pages

  Villena, I ^a   Ancelle, T ^b   Delmas, C ^a,c   Garcia, P ^d   Brezin A P ^e   Thulliez, P ^f   Wallon, M ^g   King, L ^h   Goulet, V ^h  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b University Paris Descartes ^*  (France)

^c HÔPITAL MAISON BLANCHE   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f Institut de Puericulture   (France)

^g CROIX ROUSSE HOSPITAL   (France)

^h INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTION; ADULT; AMNIOCENTESIS; ARTICLE; CHILD; CONGENITAL TOXOPLASMOSIS; DISEASE SEVERITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ECHOGRAPHY; FEMALE; FETUS; FETUS DEATH; FIRST TRIMESTER PREGNANCY; FRANCE; HUMAN; INCIDENCE; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL PERIOD; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREVALENCE; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

EID: 77954579171     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.15.25.19600-en     Document Type: Article

References (24)

1. Desmonts G, Couvreur J. Toxoplasmosis. In: Conn RB, editor. Current diagnosis. Philadelphia: WB Saunders; 1974. p. 274-97.
2. Berger F, Goulet V, Le Strat Y, Desenclos JC. Toxoplasmose chez les femmes enceintes en France: évolution de la séroprévalence et de l'incidence et facteurs associés, 1995-2003 [Toxoplasmosis in pregnant women in France: trends in seroprevalence and incidence, and associated factors, 1995-2003]. Bull Epidemiol Hebd. 2008;14-15:117-21. [Article in French].
3. Berger F, Goulet V, Le Strat Y, Desenclos JC.Toxoplasmosis among pregnant women in France: Risk factors and change of prevalence between 1995 and 2003. Rev Epidemiol Sante Publique. 2009;57(4):241-8.
4. French Food Safety Agency (AFSSA). Toxoplasma gondii: present knowledge and risk assessment of foodborne toxoplasmosis. Maison Alfort: AFSSA; 2005.
5. Dunn D, Wallon M, Peyron F, Pertersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353 (9167):1829-33.
6. Ajzenberg D, Cogné N, Paris L, Bessières MH, Thulliez P, Filisetti D, et al. Genotytpe of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis and correlation with clinical findings. J Infect Dis. 2002;186(5):684-9.
7. Roizen N, Kaska K, Karrison T, Mets M, Noble AG, Boyer K, et al. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies. Pediatrics. 2006;118(2):e379-90.
8. Wallon M, Kodjikian L, Binquet C, Garweg J, Fleury J, Quantin C, et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics. 2004; 113(6):1567-72.
9. King L, Villena I, Ancelle T, Wallon M, Garcia P, Thulliez P, et al. Congenital toxoplasmosis: implementation of a surveillance system in France. Bull Epidemiol Hebd. 2008; 14-15:122-24. [Article in French].
10. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis. 1996;15(10):799-805.
11. Paul M, Petersen E, Pawlowski ZS, Szczapa J. Neonatal screening for congenital toxoplasmosis in the Poznañ region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J. 2000;19(1):30-6.
12. Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002. Arch Dis Child. 2006;91(8):661-5.
13. Signorell LM, Seitz D, Merkel S, Berger R, Rudin C. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland,1982-1999. Pediatr Infect Dis J. 2006;25(2):123-8.
14. Evengård B, Petersson K, Engman ML, Wiklund S, Ivarsson SA, Teär-Fahnehjelm K, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect. 2001;127(1):121-7.
15. Gilbert R, Tan HK, Cliffe S, Guy E, Stanford M. Symptomatic toxoplasma infection due to congenital and postnatally acquired infection. Arch Dis Child. 2006;91(6):495-8.
16. Gilbert R, Tan HK, Cliffe S, Guy E, Stanford M. Symptomatic toxoplasma infection due to congenital and postnatally acquired infection. Erratum in: Arch Dis Child. 2006;91(7):625.
17. Cornu E, Bissery A, Malbos C, Garwig R, Cocherel C, Ecochard R, et al. Factors affecting the adherence to an antenatal screening programme: an experience with toxoplasmosis screening in France. Eurosurveillance. 2009;14(9). pii=19137. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19137
18. Desmonts G, Couvreur J. Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy]. Ann Pediatr (Paris). 1984;31(10):805-9. [Article in French].
19. Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatric. 2005;94(12):1721-31.
20. Kieffer F, Wallon M, Garcia P, Thulliez P, Peyron F, Franck J. Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis. Pediatr Infect Dis J. 2008;27(1):27-32.
21. Freeman K, Tan HK, Prusa A, Petersen E, Buffolano W, Malm G, et al. European Multicentre Study on Congenital Toxoplasmosis. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics. 2008;121(5):1215-22.
22. SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, Thiébaut R, Leproust S, Che^ne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 2007;369(9556):115-122.
23. Bénard A, Petersen E, Salamon R, Chêne G, Gilbert R, Salmi LR, et al. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill. 2008;13(15). pii=18834. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18834.
24. Ancelle T, Yera H, Talabani H, Lebuisson A, Thulliez Ph, Dupouy-Camet J. [How to reduce the costs of screening for toxoplasmosis in pregnant women?]. Rev Epidemiol Sante Publique. 2009;57(6):411-7. [Article in French].